Diederik Stadig
Diederik Stadig is a health care sector economist for ING, focusing on the implications of economic policies on the pharmaceutical industry. He has analyzed how tariffs can impact drug prices and the accessibility of medications for consumers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.13% | +0% | 331,002,651 | 430,993 | $21,000,000 | 27,344$ |
| Totals | 1 | 331,002,651 | 430,993 | $21,000,000 | 27,344$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Diederik Stadig, senior healthcare economist at financial institution ING, commented on Trump's claim.
5
United States:
Diederik Stadig, health care sector economist for ING, wrote in a post last week.
5
United States:
Diederik Stadig wrote about the conflicting policy goals for Trump regarding pharmaceuticals.
5